Escalating Loading Dose Regimens of Ticagrelor in Primary Percutaneous Intervention

A Second Opportunity for IIb/IIIa Inhibitors?

Full metrics information requires a subscription or purchase to view. If you are a subscriber or member, click the login link or the subscribe link in the top menu above to access this article.